Clinical Trials Browser

Phase 1/2 × Metastatic Castration-resistant Prostate Cancer × 90 days × Clear all

NCT05682443 2026-05-22

PRESERVE-006

Phase 1/2 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

NCT05125016 2026-05-05

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

Phase 1/2 Recruiting

Metastatic Castration-resistant Prostate Cancer